首页> 外文会议>SPIE Medical Imaging Conference >Development of a validation instrument in myocardial perfusion imaging, results of first flow experiments
【24h】

Development of a validation instrument in myocardial perfusion imaging, results of first flow experiments

机译:心肌灌注成像验证仪的开发,首次流程实验的结果

获取原文

摘要

Institutional diagnostic workflows regarding coronary artery disease (CAD) may differ greatly. Myocardial perfusion imaging (MPI) is a commonly used diagnostic method in CAD, whereby multiple modalities are deployed to assess relative or absolute myocardial blood flow (MBF) (e.g. with SPECT, PET, MR, CT, or combinations). In line with proper clinical decision-making, it is essential to assess institutional MPI test validity by confronting MBF assessment to a ground truth. Our research focuses on developing such validation instrument/method for MPI by means of simulating controlled myocardial perfusion in a phantom flow setup. A first step was made in the process of method development and validation by specifying basic requirements for the phantom flow setup. First tests in CT-MPI were aimed to gain experience in clinical testing, to verify to which extent the set requirements are met, and to evaluate the steps needed to further improve accuracy and reproducibility of measurements.The myocardium was simulated as a static cylinder and placed in a controllable pulsatile flow circuit whereby using flow sensors as reference. First flow experiments were performed for different stroke volumes (20-35 mL/stroke). After contrast injection, dynamic MPI-CT scans (SOMATOM Force, Siemens) were obtained to investigate the relation between first-pass measured and computed flow. We observed a moderate correlation; hence, the required accuracy and reproducibility levels were not met. However, we have gained new insights in factors regarding the measurement setup and MBF computation process that might affect instrument validation, which we will incorporate in future flow setup design and testing.
机译:有关冠状动脉疾病(CAD)的机构诊断工作流程可能会有很大差异。心肌灌注成像(MPI)是CAD中常用的诊断方法,通过这种方法可以采用多种方式评估相对或绝对心肌血流(MBF)(例如,使用SPECT,PET,MR,CT或组合)。与正确的临床决策相一致,必须通过将MBF评估与基本事实相抵触来评估机构MPI测试的有效性。我们的研究重点是通过模拟幻像流设置中的受控心肌灌注,开发针对MPI的验证工具/方法。通过指定幻像流设置的基本要求,在方法开发和验证过程中迈出了第一步。 CT-MPI的首次测试旨在获得临床测试经验,以验证满足设定要求的程度,并评估进一步提高测量准确性和可重复性所需的步骤。放置在可控制的脉动流量回路中,从而使用流量传感器作为参考。针对不同的冲程量(20-35 mL /冲程)进行了首次流量实验。对比剂注入后,获得动态MPI-CT扫描(SOMATOM Force,西门子)以研究初次通过流量与计算流量之间的关系。我们观察到中等程度的相关性;因此,没有达到所需的准确性和可重复性水平。但是,我们在有关可能影响仪器验证的测量设置和MBF计算过程的因素方面获得了新的见解,并将在以后的流量设置设计和测试中纳入这些因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号